This second set of human TMA analyses further confirms that CCL2/STAT3/Snail could be important markers with prognostic value, and targeting the CCL2/CCR2 axis may represent a potential new therapeutic approach to battle PCa, especially preventing the development of CRPC. Here, CCR2 is linked to posterior cortical atrophy.